Neurotransmitter correlates of impulsive aggression in humans

Annals of the New York Academy of Sciences

Volumn 794, Issue , 1996, Pages 82-89

  Coccaro, Emil F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; OPIATE; SEROTONIN; VASOPRESSIN;

AGGRESSION; BEHAVIOR; CONFERENCE PAPER; HUMAN;

EID: 0029828550     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32511.x     Document Type: Conference Paper

References (55)

1. BUSS, A. H. 1961. The Psychology of Aggression. J. Wiley & Sons. New York.
2. ASBERG, M., L. TRAKSMAN & P. THOREN. 1976. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch. Gen. Psychiatry 33: 1193-1197.
3. BROWN, G. L., F. K. GOODWIN, J. C. BALLENGER, P. F. GOYER & L. F. MAJOR. 1979. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1: 131-139.
4. BROWN, G. L., M. H. EBERT, P. F. GOYER, D. C. JIMERSON, W. J. KLEIN, W. E. BUNNEY & F. W. GOODWIN. 1982. Aggression, suicide, and serotonin: Relationships to CSF amine metabolites. Am. J. Psychiatry 139: 741-746.
5. LINNOILA, M., M. VIRKKUNEN, M. SCHEININ, A. NUUTILA, R. RIMON & F. K. GOODWIN. 1983. Low cerebrospinal fluid 5-HIAA concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33: 2609-2614.
6. LIMSON, R., D. GOLDMAN, A. ROY, D. LAMPARSKI, B. RAVITZ, B. ADINOFF & M. LINNOILA. 1991. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch. Gen. Psychiatry 48: 437-441.
7. KRUESI, M. J. P., J. L. RAPOPORT, S. HAMBERGER, E. HIEBS, W. Z. POTTER, M. LENANE & G. L. BROWN. 1990. CSF metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch. Gen. Psychiatry 47: 419-462.
8. HIGLEY, J. D., P. T. MEHLMAN, D. M. TAUB, S. B. HIGLEY, S. J. SUOMI, M. LINNOILA & J. H. VICKERS. 1992. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch. Gen. Psychiatry 49: 436-441.
9. MEHLMAN, P. T., J. D. HIGLEY, I. FAUCHER, A. A. LILLY, D. M. TAUB, J. VICKERS, S. J. SUOMI & M. LINNOILA. 1994. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in non-human primates. Am. J. Psychiatry 151: 1485-1491.
10. ROY, A., B. ADINOFF & M. LINNOILA. 1988. Acting out hostility in normal volunteers: Negative correlation with levels of 5-HIAA in cerebrospinal fluid. Psychiatry Res. 24: 187-194.
11. GARDNER, D. L., P. B. LUCAS & R. W. COWDRY. 1990. CSF metabolites in borderline personality disorder compared with normal controls. Biol. Psychiatry 28: 247-254.
12. STANLEY, M. S., J. VIGGILIO & S. GERSHON. 1992. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216: 1337-1339.
13. STANLEY M. & J. J. MANN. 1983. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1: 214-216.
14. 3-H-imipramine binding sites on platelets of conduct disordered children. Neuropsychopharmacology 1: 55-62.
15. BIRMAHER, B., M. STANLEY, L. GREENHILL, J. TWOMEY, A. GAVRILESCU & H. RABINOVITCH. 1990. Platelet imipramine binding in children and adolescents with impulsive behavior. J. Am. Acad. Child Adolesc. Psychiatry 29: 914-918.
16. MARAZZITI, D., A. ROTONDO, S. PRESTA, M. L. PANIOLI-GUADAGNUCCI, L. PALEGO & L. CONTI. 1993. Role of serotonin in human aggressive behavior. Aggressive Behav. 19: 347-353.
17. BROWN, C. S., T. A. KENT, S. G. BRYANT, R. M. GEVEDON, J. L. CAMPBELL, A. R. FELTHOUS, E. S. BARRATT & R. M. ROSE. 1989. Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res. 27: 5-12.
18. 2 receptor binding on blood platelets of suicidal men. Psychopharmacol. 100: 165-167.
19. PANDY, G. N., S. C. PANDEY, P. G. JANICAK, R. C. MARKS & J. M. DAVIS. 1990. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol. Psychiatry 28: 215-222.
20. COCCARO, E. F., L. J. SIEVER, H. KLAR, G. MAURER, K. COCHRANE, T. B. COOPER, R. C. MOHS & K. L. DAVIS. 1989. Serotonergic studies in affective and personality disorder patients. Arch. Gen. Psychiatry 46: 587-599.
21. LOPEZ-IBOR, J. J., F. LANA & J. SAIZ RUIZ. 1990. Conduct as autoliticas impulsivas y serotonina. Actas Luso Esp. Neurol. Psiquiatr. 18: 316-325.
22. SIEVER, L. & R. L. TRESTMAN. 1993. The serotonin system and aggressive personality disorder. Int. Clin. Psychopharmacol. 8(Suppl. 2): 33-39.
23. BOTCHIN, M. B., J. R. KAPLAN, S. B. MANUCK & J. J. MANN. 1993. Low versus high prolactin responders to fenfluramine challenge: Marker of behavioral differences in adult male cynmolgus macaques. Neuropsychopharmacology 9: 93-99.
24. O'KEANE, V., E. MOLONEY, H. O'NEILL, A. O'CONNOR, C. SMITH & T. G. DINAN. 1992. Blunted prolactin responses to d-fenfluramine in sociopathy: Evidence for subsensitivity of central serotonergic function. Br. J. Psychiatry 160: 643-646.
25. MOSS, H. B., J. K. YAO & G. L. PANZAK. 1990. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol. Psychiatry 28: 325-338.
26. COCCARO, E. F., S. GABRIEL & L. J. SIEVER. 1990. Buspirone challenge: Preliminary evidence for a role for central 5-HT-1a receptor function in impulsive aggressive behavior in humans. Psychopharmacol. Bull. 26: 393-405.
27. FISHBEIN, D. H., D. LOZOVSKY & J. H. JAFFE. 1989. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol. Psychiatry 25: 1049-1066.
28. BERNSTEIN, D. P. & L. HANDLESMAN. 1995. The neurobiology of substance abuse and personality disorders. In Neuropsychiatry of Behavior Disorders. J. J. Ratey, Ed.: 120-148. Blackwell Scientific Publications, Inc. Oxford, England.
29. HALPERIN, J. M., V. SHARMA, L. J. SIEVER, S. T. SCHWARTZ, K. MATIER, G. WORNELL & J. H. NEWCORN. 1994. Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am. J. Psychiatry 151: 243-248.
30. STOFF, D. M., A. P. PASTIEMPO, J. H. YEUNG, T. B. COOPER, W. H. BRIDGER & H. RABINOVICH. 1992. Neuroendocrine responses to challenge with d,l-fenfluramine and aggression in disruptive behavior disorders of children and adolescents. Psychiatry Res. 43: 263-276.
31. STOLK, J. M., R. L. CONNOR, S. LEVINE & J. D. BARCHUS. 1974. Brain norepinephrine metabolism and shock induced fighting behavior in rats: Differential effects of shock and fighting on the neurochemical response to a common footshock stimulus. J. Pharmacol. Exp. Ther. 190: 193-209.
32. EICHELMAN, B. & J. BARCHUS. 1975. Facilitated shock-induced aggression following antidepressant medication in the rat. Pharmacol. Biochem. Behav. 3: 601-604.
33. YUDOFSKY, S. C., J. M. SILVER & S. E. SCHNEIDER. 1987. Pharmacologic treatment of aggression. Psychiatr. Ann. 17: 397-406.
34. SOLOFF, P. H., A. GEORGE, R. S. NATHAN, P. M. SCHULZ & J. M. PEREL. 1986. Paradoxical effects of amitriptyline in borderline patients. Am. J. Psychiatry 143: 1603-1605.
35. ROY, A., J. DEJONG & M. LINNOILA. 1989. Extraversion in pathological gamblers: Correlates with indexes of noradrenergic function. Arch. Gen. Psychiatry 46: 679-681.
36. VIRKKUNEN, M., A. NUUTILA, F. K. GOODWIN & M. LINNOILA. 1987. Cerebrospinal fluid metabolite levels in male arsonists. Arch. Gen. Psychiatry 44: 241-247.
37. BARRETT, J. A., H. EDINGER & A. SIEGEL. 1990. Intrahypothalamic injections of norepinephrine facilitate feline affective aggression via alpha-2 adrenoceptors. Brain Res. 525: 285-293.
38. COCCARO, E. F., T. LAWRENCE, R. TRESTMAN, S. GABRIEL, H. M. KLAR & L. J. SIEVER. 1991. GH responses to IV clonidine challenge correlates with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatry Res. 39: 129-139.
39. ORDWAY, G. A., P. S. WIDDOWSON, K. S. SMITH & A. HALARIS. 1994. Agonist binding to alpha-2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 63: 617-624.
40. MARKS, P., M. O'BRIEN & G. PAXINOS. 1977. 5,7-DHT-induced muricide: Inhibition as a result of exposure of rats to mice. Brain Res. 135: 383-388.
41. LAMMERS, A. J. J. C. & J. M. VANROSSUM. 1968. Bizarre social behavior in rats induced by a combination of a peripheral decarboxylase inhibitor and DOPA. Eur. J. Pharmacol. 5: 103-106.
42. SENAULT, B. 1970. Comportement d'agressivite intraspecifique induit par l'apomorphine chez le rat. Psychopharmacologia 18: 271-287.
43. THOA, N. B., B. EICHELMAN & K. Y. NG. 1972. Shock-induced aggression: Effects of 6-hydroxydopamine and other pharmacological agents. Brain Res. 43: 467-475.
44. DATLA, K. P., A. P. SEN & S. K. BHATTACHARYA. 1992. Dopaminergic modulation of footshock induced aggression in paired rats. Indian J. Exp. Biol. 30: 587-591.
45. NIKULINA, E. M. & N. S. KAPRALOVA. 1991. The role of dopamine receptors in controlling mouse aggressivity: The genotype dependence. Zh. Vyssh. Nervn. Deyat. Im. I. P. Pavlova 41: 734-740.
46. MONTGOMERY, S. A. & D. MONTGOMERY. 1982. Pharmacological prevention of suicidal behavior. J. Affect. Dis. 4: 219-298.
47. PITCHOT, W., M. HANSENNES, A. GONZALEZ-MORENO & M. ASSEAU. 1992. Suicidal behavior and growth hormone response to apomorphine test. Biol. Psychiatry 31: 1213-1219.
48. POST, R. M., D. PICKAR, J. C. BALLENGER, D. NABER & D. R. RUBINOW. 1984. Endogenous opiates in cerebrospinal fluid: Relationship to mood and anxiety. In R. M. POS & J. C. Ballenger, Eds.: 356-368. Williams & Wilkins. Baltimore.
49. COID, J., B. ALLOLIO & L. H. REES. 1983. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 2: 545-546.
50. KONECKI, P. E. & S. C. SCHULZ. 1989. Rationale of clinical trials of opiate antagonists in treating patients with personality disorders and self-injurious behavior. Psychopharmacol. Bull. 25: 556-563.
51. KRAEMER, G. W. & A. S. CLARKE. 1990. The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 14: S141-S168.
52. GARDNER, D. L. & R. W. COWDRY. 1985. Suicidal and parasuicidal behavior in borderline personality disorder. Psychiatr. Clin. N. Am. 8: 389-403.
53. GROSS-ISSEROFF, R., K. A. DILLON, M. ISRAELI & A. BIEGNON. 1990. Regionally selective increases in mu opioid receptor density in the brains of suicidal victims. Brain Res. 530: 312-316.
54. SONNE, S., R. RUBEY, K. T. BRADY, R. MALCOLM & T. MORRIS. 1993. Naltrexone for self-injurious thoughts and actions. New Research Abstracts (NR 138), 146th Meeting of the American Psychiatric Association, San Francisco.
55. FERRIS, C. F. & Y. DELVILLE. 1994. Vasopressin and serotonin interactions in the control of agonistic behavior. Psychoneuroendocrinology 19: 593-601.